Friday, July 10, 2026

pharma · Scabies · Bioequivalence trial in healthy volunteers

Alphapharm

Alphapharm Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Scabies, Bioequivalence trial in healthy volunteers, moderate to severely inflamed candidiasis of the skin, Mild to mod

Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU HQ
1982 Founded
187 Employees
TGA registrant Type
Company details
Status
Public
HQ
Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
Founded
1982
Employees
187
Programs
30
Drugs
235
Patents
12
Clinical program

23-03/Iver-C

Phase 3 · small molecule · Papulopustular Rosacea

23-03/Iver-C for Papulopustular Rosacea is a Phase 3 program (small_molecule) at Alphapharm Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Alphapharm Pty Ltd projects Phase 3 small molecule active

Internal code 23-03/Iver-C

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Alphapharm Pty Ltd
Phase
Phase 3
Modality
small_molecule
Indication
Papulopustular Rosacea
Status
active
Trials
1